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Abstract 
 
Bacterial meningitis is a life threatening infection associated with cognitive impairment 
in many survivors. The pathogen invades the CNS by penetrating through the luminal 
side of the cerebral endothelium, which is an integral part of the BBB. Microglia are the 
resident macrophages of the CNS which can trigger a host of immunological pathways. 
The inflammatory response from microglial activation can facilitate the elimination of 
invasive microorganisms; however, excessive or extended microglial activation can 
result in neuronal damage and eventually cell death. The inhibition of microglia using 
minocycline can be a relevant pharmacological tool to study the role of microglia in 
different CNS diseases. In this study, animals received either artificial cerebrospinal 
fluid or a Streptococcus pneumoniae suspension. The animals receive minocycline or 
saline immediately after induction. For the evaluation of the BBB integrity, the animals 
were killed at 12, 18 and 24 h after induction. For the behavioural tests, ten days after 
meningitis was induced, were subjected to open-field habituation and the step-down 
inhibitory task. In both cerebral structures the use of the minocycline prevented BBB 
disruption. In the behavioural tests the use of minocycline prevented habituation and 
aversive memory impairment in the meningitis/minocycline group when compared with 
meningitis/saline. Our results demonstrate that the minocycline was able to decrease 
long-term cognitive impairment and BBB dysfunction in rats survivors of meningitis 
representing a new pharmacological approach towards pneumococcal meningitis. 
 
Keywords: Bacterial meningitis, minocycline, microglia, cognitive impairment, blood-
brain barrier. 
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Introduction 
 
Bacterial meningitis is a life threatening disease with fatality rates of 
approximately 26% and it is supposed that brain dysfunction may be associated with 
long-term cognitive impairment in approximately 26% survivors [1,2]. Previous studies 
on cognitive outcomes after pneumococcal meningitis showed reduced psychomotor, 
slight mental slowness, impairment in attention and executive functions, and learning 
and memory deficiencies [2,1,3]. Replication of microorganism within the subarachnoid 
space occurs at the same time with the release of their compounds, such as 
peptidoglycan bacteria within the subarachnoid space occurs at the same time with the 
release of their compounds, such as peptidoglycan, lipoteichoic acid, flagellin, 
lipopolysaccharide (LPS), DNA and cell wall fragment. These compounds are known as 
pathogen-associated molecular patterns (PAMPs). These PAMPs are recognised by 
pattern-recognition receptors (PRRs), which are the pivotal components of the innate 
immune system [4,5] which stimulates the production of cytokines and other pro-
inflammatory molecules in response to bacterial stimuli [6]. In response to 
inflammatory stimuli, leukocyte cells leave the blood and migrate into the site of 
infection [7]. These cells produce quantities of nitric oxide and superoxide anion, and 
this leads to lipid peroxidation, DNA single strand breaks, matrix metalloproteinase 
(MMP) activation, mitochondrial injury, blood-brain barrier (BBB) breakdown and 
brain impairment [8,9].  
Microglia are known for playing a key role in mediating inflammatory processes 
associated with various diseases [10] and can be activated by many stimuli including 
PAMPs, DAMPs or pro-inflammatory mediators to produce cytokines, chemokines, and 
reactive oxygen and nitrogen species which are involved in eliminating the invading 
microorganism. Damage to the central nervous system (CNS) during bacterial 
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meningitis involves pathogenic mechanisms of bacteria and the innate immune host 
response [11,12]. Minocycline is a semisynthetic second generation tetracycline that 
have anti-inflammatory, antioxidant, anti-apoptotic, and neuroprotective effects on 
microglial cells in rodent models [13]. The inhibition of microglia using minocycline 
can be a relevant pharmacological tool to study the role of microglia in different CNS 
diseases [14].  
The aim of this study was to investigate the effects of minocycline on integrity 
of BBB memory in an experimental model of pneumococcal meningitis. 
 
2. Experimental procedures  
2.1. Infecting organisms 
Streptococcus pneumoniae serotype III was cultured overnight in 10 mL of Todd 
Hewitt Broth, Himedia® and then diluted in fresh medium and grown to logarithmic 
phase. The culture was centrifuged for 10 min at 5,000 x g and re-suspended in sterile 
saline to a concentration of 5 x 10
9 
colony-forming units (CFU). The size of the 
inoculum was confirmed by quantitative cultures [15]. 
 
2.2. Meningitis animal model  
Adult male 60-day-old Wistar rats (250-300 g body weight) from our breeding 
colony were used for the experiments. All procedures were approved by the Animal 
Care and Experimentation Committee of UNESC (029/2015-1), Brazil, and were in 
accordance with the National Institute of Health Guide for the Care and Use of 
Laboratory Animals (NIH Publications No. 80-23), revised in 1996. All surgical 
procedures and bacterial inoculations were performed under anaesthesia consisting of an 
intraperitoneal injection of ketamine (6.6 mg/kg), xylazine (0.3 mg/kg), and 
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acepromazine (0.16 mg/kg) [16]. The animals received an intracisternal (i.c.) injection 
of 10 µL of artificial cerebrospinal fluid (CSF) as a placebo or an equivalent volume of 
S. pneumoniae suspension. At the time of the inoculation, the animals received fluid 
replacement and were subsequently returned to their cages. Eighteen hours after the 
induction of meningitis, the infection was documented by a quantitative culture of 5 µL 
of CSF by puncturing the cisterna magna [15].  
 
2.3 Treatment 
The animals receive minocycline (100 µg/Kg icv) immediately after induction 
(dissolved in sterile saline, 0.5 μL i.c., Sigma-Aldrich, Saint Louis, USA) or saline [17]. 
To evaluate the behavioural response, the animals were separated into four groups: 
control/saline, control/ minocycline, meningitis/saline, and meningitis/ minocycline (n = 
10 animals per group; n = 80). Eighteen hours after induction, all animals received 
ceftriaxone (100 mg/kg body weight given s.c./7 days) [18]. To evaluate the BBB 
integrity, the animals were separated in the same groups. 
 
2.4 BBB permeability to Evan’s blue 
We investigated the BBB integrity by Evan’s blue dye extravasation (Smith and 
Hall, 1996) at 12, 18 and 24 h after pneumococcal meningitis induction (n = 5-6). One 
mL of Evan’s blue at 1% was injected in all animals intraperitoneally1 h before being 
killed. The anesthesia consisted of an intraperitoneal administration of ketamine (6.6 
mg/kg), xylazine (0.3 mg/kg), and acepromazine (0.16 mg/kg) [19]. The animal’s chests 
were opened, and the brain was perfused with 200 mL of sterile saline through the left 
ventricle at a pressure of 100 mmHg until colorless perfusion fluid was found from the 
right atrium. The brains were weighed and stored in trichloroacetic solution at 50% 
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concentration. Ethanol (1:3) was used as diluent of extracted dye and its fluorescence 
was determined (excitation at 620 nm and emission at 680 nm) with a luminescence 
spectrophotometer (Hitachi 650-40, Tokyo, Japan). The tissue content Evan’s blue was 
measured from a linear standard line derived from known quantities of the dye, and it 
was expressed per gram of tissue [20]. 
 
2.5 Behavioural tasks  
Ten days after inoculation, the animals were free from infection. All blood 
cultures that were performed during this period were negative. Finally, the animals were 
randomised and subjected to the open-field habituation and step-down inhibitory 
avoidance tasks. 
  
2.5.1. Open field task 
Behaviour was assessed in an open-field apparatus to evaluate both locomotor 
and exploratory activity. The apparatus was a 40 × 60 cm open field surrounded by 50-
cm-high dark grey walls and a front glass wall. Black lines divided the floor of the open 
field into nine rectangles. Each animal was gently placed in the centre of the open field 
and was left to explore the arena for 5 min (training session). The number of crossings 
(i.e., the number of times that the animal crossed the black lines, an assessment of 
locomotor activity) and rearing movements (i.e., the exploratory behaviour observed in 
rats subjected to a new environment) were measured. Immediately after this procedure, 
the animals were taken back to their home cage. Twenty-four hours later, they were 
subjected to a second open-field session (test session). In both sessions, the number of 
times the animal crossed the black lines or reared was counted during a 5-min period. 
The reduction in the number of crossings and rearings between the two sessions was 
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taken as a measure of the retention of memory. The behavioural test was performed by 
the same person (manual analyses) who was blind to the group treatment [21]. 
 
2.5.2. Step-down inhibitory avoidance task 
The apparatus and procedures have been described in previous reports [22,23]. 
Briefly, the training apparatus was a 50 x 25 x 25 cm acrylic box (Albarsch, Porto 
Alegre, Brazil), whose floor consisted of parallel calibre stainless steel bars (1 mm 
diameter) spaced 1 cm apart. A 7-cm-wide, 2.5-cm-high platform was placed on the 
floor of the box, against the left wall. In the training trial, animals were placed on the 
platform, and their latency to step down on the grid with all four paws was measured 
with an automatic device. Immediately after stepping down on the grid, the animals 
received a 0.4 mA, 2.0 s foot shock and were returned to their home cage. A retention 
test trial was performed 1.5 h (short-term memory), and 24 h after training (long-term 
memory). The retention test trial was procedurally identical to the training trial, except 
that no foot shock was administered. The retention test step-down latency (maximum, 
180 s) was used as a measure of inhibitory avoidance retention [24,25] 
 
3. Statistics 
Data were analysed for normality by the Shapiro–Wilk test and for homogeneity 
using the Levene test. When the data were normal and homogeneity of variance, 
parametric tests was used, not meeting this condition, non-parametric tests were used. 
The results of the BBB integrity are reported as the mean ± SD of 5-6 animals in each 
group. Differences among groups were evaluated using analysis of variance (ANOVA) 
followed by the Student Newman–Keuls post-hoc test.  Data from the inhibitory 
avoidance task are reported as median and interquartile ranges, the comparisons among 
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groups were performed using a Mann–Whitney U-test. The within-individual group 
comparisons were made by Wilcoxon's tests. Data from the habituation to open field 
task are reported as the mean ± SD and comparisons among groups were analysed by 
paired Student’s t-tests and analysis of variance with post-hoc Tukey’s tests. P values 
*p<0.05 were considered statistically significant. All analyses were performed using the 
Statistical Package for the Social Science (SPSS) software version 20.0. 
 
4. Results 
 
In figure 1, we evaluated BBB integrity in the hippocampus (A) and cortex (B) 
at 12, 18 and 24 h after pneumococcal meningitis induction in animals administered 
adjuvant treatment minocycline. In both structures, hippocampus and cortex, the use of 
the minocycline prevented BBB disruption (p<0.05).  
Figures 2 and 3 illustrate the effects of minocycline on the memory of adult 
Wistar rats subjected to S. pneumoniae-induced meningitis. Meningitis group rats 
subjected to the open-field habituation task showed no difference between their training 
and test sessions, demonstrating memory impairment (p > 0.05). However, in the 
control, control/ minocycline and meningitis/ minocycline groups, there were 
differences in the number of crossings and rearings between the training and test 
sessions, demonstrating memory habituation (p < 0.05; figure 2A and 2B).  
In the step-down inhibitory avoidance task, there was a difference between the 
training and test sessions in the control, control/minocycline and 
meningitis/minocycline groups, demonstrating aversive short- and long-term memory in 
these groups (p < 0.05). In the meningitis group, there was no difference between the 
training and test sessions, demonstrating impairment of short- and long-term aversive 
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memory in these mice (p > 0.05; figure 3). 
 
5. Discussion 
 
In the present study, we demonstrated the influence minocycline on BBB 
integrity and on learning and memory in an animal model of pneumococcal meningitis. 
Microglia cells maintain cellular, synaptic, and myelin homeostasis during 
development, normal function of the CNS and in response to CNS injury. Thus, 
microglia have been shown to mediate a myriad of aspects of neuroinflammation, 
including recognition of pathogens bound to MHC for activation of T lymphocytes, 
phagocytosis, cytotoxicity through production of cytokines and secretion of glutamate, 
aspartate, reactive oxygen and nitrogen species [26].  
In previous studies, we verified BBB disruption at 12, 18 and 24 h after 
pneumococcal meningitis induction in the hippocampus and cortex [27]. In this study, 
we observed the breakdown of the BBB in the hippocampus and cortex at 12, 18 and 24 
h after induction and treatment with minocycline prevented this dysfunction. The 
immune response, the production of cytokines, and leukocyte migration are first line of 
defense against to bacterial infection [28]. Leukocytes produce nitric oxide, superoxide 
anion radicals and hydrogen peroxide that can lead to the formation of peroxynitrite 
[29], which is a strong oxidant that exerts cytotoxic effects on endothelial cells [30], 
increases the BBB permeability [31], and provokes lipid peroxidation, mitochondrial 
damage and matrix metalloproteinases activation [29]. The decrease of microglia 
activation by minocycline was able to prevent the disruption of the BBB in the 
hippocampus and cortex of Wistar rats after induction meningits. Michels e co-works, 
demonstrated that use of minocycline prevented breakdown of the BBB in rats 
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submitted to experimental model of sepsis [32]. 
It has been well established that bacterial meningitis survivors present long-term 
cognitive impairment. We have already demonstrated that rats who survived 
pneumococcal meningitis presented learning and memory impairment 10 days after 
pneumococcal meningitis induction [33] . The present study demonstrated that adjuvant 
treatment with minocycline prevented short- and long-term aversive memory 
impairments, as well as open-field habituation memory. The use the minocycline 
prevents long-term memory impairment and hippocampal inflammation in rats that are 
neonatally infected with Escherichia coli [34]. Lam and colleagues (2013) demonstrated 
that chronic administration of minocycline attenuated neuroinflammation and prevented 
injury memory impairment after traumatic brain injury [35]. 
Despite evidence that microglia activation is associated with brain injury, its role 
in the long-term cognitive impairment is not clear. Our results demonstrate that the 
inhibition of the microglia by minocycline was able to decrease long-term cognitive 
impairment and BBB disfunction in rats survivors of bacterial meningits possibly 
representing a new pharmacological approach towards pneumococcal meningitis. Future 
studies must be realized to understand the underlying mechanisms. 
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Legends to figures 
 
 
Fig. 1 Evaluated the integrity of BBB using Evan’s blue dye extravasation in 
hippocampus (A) and cortex (B) at 12, 18 and 24 h after S. pneumoniae meningitis 
induction. Differences among groups were evaluated using analysis of variance 
(ANOVA) followed by the Student Newman–Keuls post-hoc test. *p < 0.05 indicates 
statistically significant differences between training and test sessions. 
#
 p < 0.05 
indicates statistical significance compared with the meningitis/saline group. 
 
Fig. 2 Effects of minocycline on the open-field habituation task by adult Wistar 
rats 10 days after the induction of pneumococcal meningitis. The numbers of 
crossing and rearing movements are reported as the mean ± SEM and were analysed by 
paired Student’s t-tests and analysis of variance with post-hoc Tukey’s tests (10 animals 
per group). *p < 0.05 indicates statistical significance compared with training.  
 
Fig. 3 Effects of minocycline on the step-down inhibitory avoidance task in adult 
Wistar rats 10 days after the induction of pneumococcal meningitis. Data are 
reported as median and interquartile ranges, and comparisons among groups were 
performed using Mann-Whitney U tests. The intra-group variations were analysed by 
Wilcoxon’s tests. *p < 0.05 indicates statistically significant differences between 
training and test sessions. 
&
 p < 0.05 indicates statistical significance compared with the 
meningitis/saline group. 
 
